USA.- The U.S. Food and Drug Administration (FDA) reports that 2 out of the 131 (1.5%) total seafood entry line refusals in October were of shrimp for reasons related to banned antibiotics.
The FDA has now refused a total of 60 entry lines of shrimp for reasons related to veterinary drug residues in 2019.
The two shrimp entry lines refused in October for veterinary drug residues were from two different exporters in India and Venezuela:
– Cochin Frozen Food Exports (India), a company that is not currently listed on Import Alert 16-124 (“Detention Without Physical Examination of Aquaculture Seafood Products Due to Unapproved Drugs”), Import Alert 16-127 (“Detention Without Physical Examination of Crustaceans Due to Chloramphenicol”), or Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”), had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of West Coast Imports on October 10, 2019; and
– Tuta Corporation (Venezuela), a company that has been listed on Import Alert 16-129 (“Detention Without Physical Examination of Seafood Products Due to Nitrofurans”) since October 18, 2017, had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of Southeast Imports on October 22, 2019.
In addition to those two entry lines, the FDA also refused another eleven entry lines of shrimp because of the presence of salmonella: seven from Indonesia (PT Surya Alam Tunggal) by the Division of Northern Border Imports; two from India (Choice Canning Company) by the Division of Northeast Imports; one from the Philippines (HJR International Corporation) by the Division of West Coast Imports; and one from Vietnam (Quang Minh Seafood Co.) by the Division of West Coast Imports.
Source: Southern Shrimp Alliance
